FDA Import Refusal 1FX-2233101-0/50002/3 — SYBIOSIS PHARMACEUTICALS PVT LTD
The FDA refused shipment 1FX-2233101-0/50002/3 from SYBIOSIS PHARMACEUTICALS PVT LTD (India) on Apr 7, 2026. The refused product falls under Drugs and Biologics — LEVOCETIRIZINE DIHYDROCHLORIDE. Cited charge: 75
Refusal Details
- Date
- Apr 7, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61XDA51 LEVOCETIRIZINE DIHYDROCHLORIDE
- Charges
- 75